Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...
Hosted on MSN15h
Will Ozempic, Wegovy be Affordable in the Near Future?Saving more, paying down debt and building wealth are top financial goals for many Americans. CNBC's Senior Personal Finance Correspondent Sharon Epperson and Anchor Kelly Evans share advice on how to ...
Weight loss drugs are seen as an easy option for dropping the pounds, but they are also expensive, and can have nasty side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback